The use of Hericium erinaceus and Trametes versicolor extracts in supportive treatment in oncology

Winder, Mateusz; Bulska-Będkowska, Weronika; Chudek, Jerzy

doi:10.2478/acph-2021-0007

Abstract

Substances available in nature with potential therapeutic effects are the subject of research that raises tremendous hopes for new challenges in medicine. Fungi are the most common organisms in the ecosystem and the most interesting in this respect. This review discusses two species of edible fungi, used for centuries in Eastern natural medicine, with the best-documented effect – Hericium erinaceus (He) and Trametes versicolor (Tv). The results of in vivo and in vitro studies conducted on mice and human cell lines demonstrate immunomodulatory, potentially, anticancer, anti-inflammatory and neuroregenerative effects of substances isolated from these fungi. The substances contained in the extracts of He and Tv seem to have immunomodulatory effects that may support chemotherapy. The use of these extracts is justified stronger than the other supportive treat ments based on supplements.

References

1. W. Sneader, Drug Discovery. A History, John Wiley & Sons, Chichester 2005.10.1002/0470015535
Search in Google Scholar Back to article
2. D. T. Courtwright, Forces of Habit – Drugs and the Making of the Modern World, Harvard University Press, Cambridge (MA) 2002.10.4159/9780674029903
Search in Google Scholar Back to article
3. M. Hanada, Case Studies in Modern Drug Discovery and Development, John Wiley & Sons, Hoboken (NJ) 2012.
Search in Google Scholar Back to article
4. D. A. Dias, S. Urban and U. Roessner, A historical overview of natural products in drug discovery, Metabolites2 (2012) 303–336; https://doi.org/10.3390/metabo202030310.3390/metabo2020303390120624957513
Search in Google Scholar Back to article
5. M. Friedman, Chemistry, nutrition, and health-promoting properties of Hericium erinaceus (Lion’s mane) mushroom fruiting bodies and mycelia and their bioactive compounds, J. Agric. Food Chem. 63 (2015) 7108–7123; https://doi.org/10.1021/acs.jafc.5b0291410.1021/acs.jafc.5b0291426244378
Search in Google Scholar Back to article
6. X. He, X. Wang, J. Fang, Y. Chang, N. Ning, H. Guo, L. Huang, X. Huang and Z. Zhao, Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion’s mane) mushroom: A review, Int. J. Biol. Macromol. 97 (2017) 228–237; https://doi.org/10.1016/j.ijbiomac.2017.01.04010.1016/j.ijbiomac.2017.01.04028087447
Search in Google Scholar Back to article
7. G. Wang, X. Zhang, S. E. Maier, L. Zhang and R. J. Maier, In vitro and in vivo inhibition of Helicobacter pylori by ethanolic extracts of Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), Int. J. Med. Mushrooms21 (2019) 1–11; https://doi.org/10.1615/IntJMedMush-rooms.201802948710.1615/IntJMedMushrooms.2018029487
Search in Google Scholar Back to article
8. M. Qin, Y. Geng, Z. Lu, H. Xu, J. S. Shi, X. Xu and Z. H. Xu, Antiinflammatory effects of ethanol extract of Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), in mice with ulcerative colitis, Int. J. Med. Mushrooms18 (2016) 227–234; https://doi.org/10.1615/IntJMedMush-rooms.v18.i3.5010.1615/IntJMedMushrooms.v18.i3.50
Search in Google Scholar Back to article
9. M. Wang, T. Konishi, Y. Gao, D. Xu and Q. Gao, Anti-gastric ulcer activity of polysaccharide fraction isolated from mycelium culture of Lion’s mane medicinal mushroom, Hericium erinaceus (higher Basidiomycetes), Int. J. Med. Mushrooms17 (2015) 1055–1060; https://doi.org/10.1615/intjmedmushrooms.v17.i11.5010.1615/IntJMedMushrooms.v17.i11.50
Search in Google Scholar Back to article
10. W. Li, W. Zhou, E. J. Kim, S. H. Shim, H. K. Kang and Y. H. Kim, Isolation and identification of aromatic compounds in Lion’s Mane Mushroom and their anticancer activities, Food Chem. 170 (2015) 336–342; https://doi.org/10.1016/j.foodchem.2014.08.07810.1016/j.foodchem.2014.08.07825306354
Search in Google Scholar Back to article
11. S. P. Kim, M. Y. Kang, Y. H. Choi, J. H. Kim, S. H. Nam and M. Friedman, Mechanism of Hericium erinaceus (yamabushitake) mushroom-induced apoptosis of U937 human monocytic leukemia cells, Food Funct.2 (2011) 348–356; https://doi.org/10.1039/c1fo10030k10.1039/c1fo10030k21779573
Search in Google Scholar Back to article
12. M. Wang, Y. Zhang, X. Xiao, D. Xu, Y. Gao and Q. Gao, A polysaccharide isolated from mycelia of the Lion’s mane medicinal mushroom Hericium erinaceus (Agaricomycetes) induced apoptosis in precancerous human gastric cells, Int. J. Med. Mushrooms19 (2017) 1053–1060; https://doi.org/10.1615/IntJMedMushrooms.201702497510.1615/IntJMedMushrooms.201702497529431066
Search in Google Scholar Back to article
13. X. Zan, F. Cui, Y. Li, Y. Yang, D. Wu, W. Sun and L. Ping, Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cell growth via cell cycle arrest and apoptosis, Int. J. Biol. Macromol. 76 (2015) 242–253; https://doi.org/10.1016/j.ijbiomac.2015.01.06010.1016/j.ijbiomac.2015.01.06025703932
Search in Google Scholar Back to article
14. Y. Li, G. Zhang, T. B. Ng and H. Wang, A novel lectin with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from dried fruiting bodies of the monkey head mushroom Hericium erinaceum, J. Biomed. Biotechnol.2010 (2010) Article ID 716515 (9 pages); https://doi.org/10.1155/2010/71651510.1155/2010/716515
Search in Google Scholar Back to article
15. S. S. Han, C. K. Cho, Y. W. Lee and H. S. Yoo, Antimetastatic and immunomodulating effect of water extracts from various mushrooms, J. Acupunct. Meridian Stud.2 (2009) 218–227; https://doi.org/10.1016/S2005-2901(09)60058-310.1016/S2005-2901(09)60058-3
Search in Google Scholar Back to article
16. X. Sheng, J. Yan, Y. Meng, Y. Kang, Z Han, G. Tai, Y. Zhou and H. Cheng, Immunomodulatory effects of Hericium erinaceus derived polysaccharides are mediated by intestinal immunology, Food Funct.8 (2017) 1020–1027; https://doi.org/10.1039/c7fo00071e10.1039/C7FO00071E28266682
Search in Google Scholar Back to article
17. I.-C. Li, L.-Y. Lee, T.-T. Tzeng, W.-P. Chen, Y.-P. Chen, Y.-J. Shiao and C.-C. Chen, Neurohealth properties of Hericium erinaceus mycelia enriched with erinacines, Behav. Neurol.2018 (2018) 5802634 (10 pages); https://doi.org/10.1155/2018/580263410.1155/2018/5802634598723929951133
Search in Google Scholar Back to article
18. P. Rossi, V. Cesaroni, F. Brandalise, A. Occhinegro, D. Ratto, F. Perrucci, V. Lanaia, C. Girometta, G. Orrù and E. Savino, Dietary supplementation of Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), and spatial memory in wild-type mice, Int. J. Med. Mushrooms20 (2018) 485–494; https://doi.org/10.1615/IntJMedMushrooms.201802624110.1615/IntJMedMushrooms.201802624129953363
Search in Google Scholar Back to article
19. P. S. Liu, S. H. Chueh, C. C. Chen, L. Y. Lee and L. Y. Shiu, Lion’s mane medicinal mushroom, Hericium erinaceus (Agaricomycetes), modulates purinoceptor-coupled calcium signaling and murine nociceptive behavior, Int. J. Med. Mushrooms19 (2017) 499–507; https://doi.org/10.1615/IntJMedMushrooms.v19.i6.2010.1615/IntJMedMushrooms.v19.i6.2029199560
Search in Google Scholar Back to article
20. C.-C. Zhang, X. Yin, C.-Y. Cao, J. Wei, Q. Zhang and J.-M. Gao, Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells, Bioorg. Med. Chem. Lett.25 (2015) 5078–5082; https://doi.org/10.1016/j.bmcl.2015.10.01610.1016/j.bmcl.2015.10.01626481911
Search in Google Scholar Back to article
21. K. Mori, S. Inatomi, K. Ouchi, Y. Azumi and T. Tuchida, Improving effects of the mushroom yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial, Phytother. Res.23 (2009) 367–372; https://doi.org/10.1002/ptr.263410.1002/ptr.263418844328
Search in Google Scholar Back to article
22. M. Nagano, K. Shimizu, R. Kondo, C. Hayashi, D. Sato, K. Kitagawa and K. Ohnuki, Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake, Biomed. Res.31 (2010) 231–237; https://doi.org/10.2220/biomedres.31.23110.2220/biomedres.31.23120834180
Search in Google Scholar Back to article
23. A. Blagodatski, M. Yatsunskaya, V. Mikhailova, V. Tiasto, A. Kagansky and V. L. Katanaev, Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy, Oncotarget9 (2018) 29259–29274; https://doi.org/10.18632/oncotarget.2566010.18632/oncotarget.25660604437230018750
Search in Google Scholar Back to article
24. L. J. Standish, C. A. Wenner, E. S. Sweet, C. Bridge, A. Nelson, M. Martzen, J. Novack and C. Torkelson, Trametes versicolor mushroom immune therapy in breast cancer, J. Soc. Integr. Oncol.6 (2008) 122–128.
Search in Google Scholar Back to article
25. K. Oba, S. Teramukai, M. Kobayashi, T. Matsui, Y. Kodera and J. Sakamoto, Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer, Cancer Immunol. Immunother.56 (2007) 905–911; https://doi.org/10.1007/s00262-006-0248-110.1007/s00262-006-0248-117106715
Search in Google Scholar Back to article
26. J. Sakamoto, S. Morita, K. Oba, T. Matsui, M. Kobayashi, H. Nakazato and Y. Ohashi, Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials, Cancer Immunol. Immunother. 55 (2006) 404–411; https://doi.org/10.1007/s00262-005-0054-110.1007/s00262-005-0054-116133112
Search in Google Scholar Back to article
27. K. Sugimachi, K. Inokuchi and H. Matsuura, Hormone conditioned cancer chemotherapy for recurrent breast cancer prolongs survival, Jpn. J. Surg.14 (1984) 217–221.10.1007/BF024695716748393
Search in Google Scholar Back to article
28. Y. Iino, T. Yokoe, M. Maemura, J. Horiguchi, H. Takei, S. Ohwada and Y. Morishita, Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer, Anticancer Res. 15 (1995) 2907–2911.
Search in Google Scholar Back to article
29. L. Zhong, P. Yan, W. C. Lam, L. Yao and Z. Bian, Coriolus versicolor and Ganoderma lucidum related natural products as an adjunct therapy for cancers: A systematic review and meta-analysis of randomized controlled trials, Front. Pharmacol. 10 (2019) 703 (14 pages); https://doi.org/10.3389/fphar.2019.0070310.3389/fphar.2019.00703661631031333449
Search in Google Scholar Back to article
30. H. Lu, Y. Yang, E. Gad, C. Inatsuka, C. A. Wenner, M. L. Disis and L. J. Standish, TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy, Clin. Cancer Res. 17 (2011) 6742–6753; https://doi.org/10.1158/1078-0432.CCR-11-114210.1158/1078-0432.CCR-11-1142320698721918170
Search in Google Scholar Back to article
31. H. Lu, Y. Yang, E. Gad, C. A. Wenner, A. Chang, E. R. Larson, Y. Dang, M. Martzen, L. J. Standish and M. L. Disis, Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells, Clin. Cancer Res. 17 (2011) 67–76; https://doi.org/10.1158/1078-0432.CCR-10-176310.1158/1078-0432.CCR-10-1763301724121068144
Search in Google Scholar Back to article
32. K. Quayle, C. Coy, L. Standish and H. Lu, The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan, J. Nat. Med. 69 (2015) 198–208; https://doi.org/10.1007/s11418-014-0879-z10.1007/s11418-014-0879-z25510899
Search in Google Scholar Back to article
33. Z. Wang, B. Dong, Z. Feng, S. Yu and Y. Bao, A study on immunomodulatory mechanism of polysaccharopeptide mediated by TLR4 signaling pathway, BMC Immunol. 16 (2015) Article ID 34 (9 pages); https://doi.org/10.1186/s12865-015-0100-510.1186/s12865-015-0100-5445099426032186
Search in Google Scholar Back to article
34. H. Dou, Y. Chang and L. Zhang, Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China, Prog. Mol. Biol. Transl. Sci. 163 (2019) 361–381; https://doi.org/10.1016/bs.pmbts.2019.03.00110.1016/bs.pmbts.2019.03.00131030754
Search in Google Scholar Back to article
35. Y. Chang, M. Zhang, Y. Jiang, Y. Liu, H. Luo, C. Hao, P. Zeng and L. Zhang, Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China, Discov. Med. 23 (2017) 207–219.
Search in Google Scholar Back to article
36. F. Hong, R.. Hansen, J. Yan D. Allendorf, J. Baran, G. Ostroff and G. Ross, Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells, Cancer Res. 63 (2003) 9023–9031; https://cancerres.aacrjournals.org/content/63/24/9023.long
Search in Google Scholar Back to article
37. S. Modak, G. Koehne, A. Vickers, R. O’Reilly and N.-K. V. Cheung, Rituximab therapy of lymphoma is enhanced by orally administered (1®3),(1®4)-D-β-glucan, Leuk. Res. 29 (2005) 679–683; https://doi.org/10.1016/j.leukres.2004.10.00810.1016/j.leukres.2004.10.00815863209
Search in Google Scholar Back to article
38. M. Thomas, P. Sadjadian, J. Kollmeier, J. Lowe, P. Mattson, J. R. Trout, M. Gargano, M. L. Patchen, R. Walsh, M. Beliveau, J. F. Marier, N. Bose, K. Gorden and F. Schneller III, A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer, Invest. New Drugs35 (2017) 345–358; https://doi.org/10.1007/s10637-017-0450-310.1007/s10637-017-0450-3541830728303530
Search in Google Scholar Back to article
39. N. H. Segal, P. Gada, N. Senzer, M. Gargano, M. Patchen and L. Saltz, A phase II efficacy and safety, open-label, multicenter study of imprime PGG injection in combination with cetuximab in patients with stage IV KRAS-mutant colorectal cancer, Clin. Colorectal Cancer15 (2016) 222–227; https://doi.org/10.1016/j.clcc.2016.02.01310.1016/j.clcc.2016.02.013562151926975418
Search in Google Scholar Back to article
40. H. Asai, H. Iijima, K. Matsunaga, Y. Oguchi, H. Katsuno and K. Maeda, Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling, Cancer Immunol. Immunother.57 (2008) 1647–1655; https://doi.org/10.1007/s00262-008-0498-110.1007/s00262-008-0498-118343922
Search in Google Scholar Back to article
41. A. L. Engel, G. C. Sun, E. Gad, L. R. Rastetter, K. Strobe, Y. Yang, Y. Dang, M. L. Disis and H. Lu, Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant, Immunobiology218 (2013) 1468–1476; https://doi.org/10.1016/j.imbio.2013.05.00110.1016/j.imbio.2013.05.001378351923735481
Search in Google Scholar Back to article
42. M. Kato, K. Hirose, M. Hakozaki, M. Ohno, Y. Saito, R. Izutani, J. Noguchi, Y. Hori, S. Okumoto, D. Kuroda, H. Nomura, S. Nishimatsu and H. Ohoyanagi, Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide, Cancer Immunol. Immunother.40 (1995) 152–156.10.1007/BF015173467728773
Search in Google Scholar Back to article
43. C. B. Lau, C. Y. Ho, C. F. Kim, K. N. Leung, K. P. Fung, T. F. Tse, H. H. Chan and M. S. Chow, Cytotoxic activities of Coriolus versicolor (yunzhi) extract on human leukemia and lymphoma cells by induction of apoptosis, Life Sci.75 (2004) 797–808; https://doi.org/10.1016/j.lfs.2004.04.00110.1016/j.lfs.2004.04.00115183073
Search in Google Scholar Back to article
44. C. Inatsuka, Y. Yang, E. Gad, L. Rastetter, M. L. Disis and H. Lu, Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK, Cancer Immunol. Immunother.62 (2013) 1335–1345; https://doi.org/10.1007/s00262-013-1436-410.1007/s00262-013-1436-4372762923685781
Search in Google Scholar Back to article
45. C. J. Torkelson, E. Sweet, M. R. Martzen, M. Sasagawa, C. A. Wenner, J. Gay, A. Putiri and L. J. Standish, Phase 1 clinical trial of Trametes versicolor in women with breast cancer, ISRN Oncol. 2012 (2012) 251632 (7 pages); https://doi.org/10.5402/2012/25163210.5402/2012/251632336947722701186
Search in Google Scholar Back to article
46. B. K. Sekhon, D. M. Sze, W. K. Chan, K. Fan, G. Q. Li, D. E. Moore and R. H. Roubin, PSP activates monocytes in resting human peripheral blood mononuclear cells: immunomodulatory implications for cancer treatment, Food Chem. 138 (2013) 2201–2209; https://doi.org/10.1016/j.food-chem.2012.11.00910.1016/j.foodchem.2012.11.009
Search in Google Scholar Back to article
47. C. A. Wenner, M. R. Martzen, H. Lu, M. R. Verneris, H. Wang and J. W. Slaton, Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer, Int. J. Oncol. 40 (2012) 905–913; https://doi.org/10.3892/ijo.2011.129210.3892/ijo.2011.1292358455522159900
Search in Google Scholar Back to article
48. Q. Y. Hu, H. Wang, W. M. Shen, X. R. Chen and M. Zou, Promoting effects of polysaccharide of Polysticius versicolor (L) FR. in C57BL/6J mice bearing melanoma B16, Chin. J. Antibiot. 6 (1988) 425–431.
Search in Google Scholar Back to article
49. S. Xu, Y. H. Song, H. Li and H. B. Cai, Curative effect observation on advanced colorectal cancer by the treatment with PSP combined with XELOX regimen, Acta Univ. Med. Nanjing12 (2008) 1616–1618.
Search in Google Scholar Back to article
50. H. Fritz, D. A. Kennedy, M. Ishii, D. Fergusson, R. Fernandes, K. Cooley and D. Seely, Polysaccharide K and Coriolus versicolor extracts for lung cancer: A systematic review, Integr. Cancer Ther. 14 (2015) 201–211; https://doi.org/10.1177/153473541557288310.1177/153473541557288325784670
Search in Google Scholar Back to article
51. A. Knežević, M. Stajić, I. Sofrenić, T. Stanojković, I. Milovanović, V. Tešević and J. Vukojević, Antioxidative, antifungal, cytotoxic and antineurodegenerative activity of selected Trametes species from Serbia, PLoS ONE13 (2018) e0203064 (18 pages); https://doi.org/10.1371/journal.pone.020306410.1371/journal.pone.0203064611837330169542
Search in Google Scholar Back to article
52. L. Janjušević, B. Pejin, S. Kaišarević, S. Gorjanović, F. Pastor, K. Tešanović and M. Karaman, Trametes versicolor ethanol extract, a promising candidate for health-promoting food supplement, Nat. Prod. Res. 32 (2018) 963–967; https://doi.org/10.1080/14786419.2017.136648410.1080/14786419.2017.136648428817965
Search in Google Scholar Back to article
53. C. Y. Ho, C. F. Kim, K. N. Leung, K. P. Fung, T. F. Tse, H. Chan and C. B. Lau, Differential anti-tumor activity of coriolus versicolor (yunzhi) extract through p53- and/or Bcl-2-dependent apoptotic pathway in human breast cancer cells, Cancer Biol. Ther. 4 (2005) 638–644; https://doi.org/10.4161/cbt.4.6.172110.4161/cbt.4.6.172115908782
Search in Google Scholar Back to article
54. D. Roca-Lema, O. Martinez-Iglesias, C. Fernández de Ana Portela, A. Rodríguez-Blanco, M. Valladares-Ayerbes, A. Díaz-Díaz, A. Casas-Pais, C. Prego and A. Figueroa, In vitro anti-proliferative and anti-invasive effect of polysaccharide-rich extracts from Trametes versicolor and Grifola frondosa in colon cancer cells, Int. J. Med. Sci.16 (2019) 231–240; https://doi.org/10.7150/ijms.2881110.7150/ijms.28811636752230745803
Search in Google Scholar Back to article
55. T.-C. Hsieh, J. Kunicki, Z. Darzynkiewicz and J. M. Wu, Effects of extracts of Coriolus versicolor (I’m-Yunity™) on cell-cycle progression and expression of interleukins-1β, -6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes, J. Altern. Complement. Med. 8 (2002) 591–602; https://doi.org/10.1089/10755530232082510110.1089/10755530232082510112470440
Search in Google Scholar Back to article
56. N. Hirahara, M. Fujioka, T. Edamatsu, A. Fujieda, F. Sekine, T. Wada and T. Tanaka, Protein-bound polysaccharide-K (PSK) induces apoptosis and inhibits proliferation of promyelomonocytic leukemia HL-60 cells, Anticancer Res. 31 (2011) 2733–2738.
Search in Google Scholar Back to article
57. T. S. Hattori, N. Komatsu, S. Shichijo and K. Itoh, Protein-bound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line, Namalwa, Biomed. Pharmacother. 58 (2004) 226–230; https://doi.org/10.1016/j.biopha.2004.02.00410.1016/j.biopha.2004.02.00415183847
Search in Google Scholar Back to article
58. C. Iguchi, Y. Nio, H. Takeda, K. Yamasawa, N. Hirahara, T. Toga, M. Itakura and K. Tamura, Plant polysaccharide PSK: cytostatic effects on growth and invasion; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface, Anticancer Res. 21 (2001) 1007–1013.
Search in Google Scholar Back to article
59. S. F. Yang, T. F. Zhuang, Y. M. Si, K. Y. Qi and J. Zhao, Coriolus versicolor mushroom polysaccha-rides exert immunoregulatory effects on mouse B cells via membrane Ig and TLR-4 to activate the MAPK and NF-κB signaling pathways, Mol. Immunol. 64 (2015) 144–151; https://doi.org/10.1016/j.molimm.2014.11.00710.1016/j.molimm.2014.11.00725480394
Search in Google Scholar Back to article
60. H. Zhang, T. Morisaki, C. Nakahara, H. Matsunaga, N. Sato, F. Nagumo, J. Tadano and M. Katano, PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1, Oncogene22 (2003) 2088–2096; https://doi.org/10.1038/sj.onc.120631010.1038/sj.onc.120631012687011
Search in Google Scholar Back to article
61. E. Jiménez-Medina, E. Berruguilla, I. Romero, I. Algarra, A. Collado, F. Garrido and A. Garcia-Lora, The immunomodulator PSK induces in vitro cytotoxic activity in tumor cell lines via arrest of cell cycle and induction of apoptosis, BMC Cancer8 (2008) Article ID 78 (10 pages); https://doi.org/10.1186/1471-2407-8-7810.1186/1471-2407-8-78229147118366723
Search in Google Scholar Back to article

The use of Hericium erinaceus and Trametes versicolor extracts in supportive treatment in oncology

Abstract

Paradigm

My account